J06AA03 • anti-viperin immunoglobulin • Antiinfectives for systemic use | Immune sera
Anti-viper venom immunoglobulin is a serum derived from the plasma of animals (usually horses) immunized specifically against viper venom. It is used to treat viper bites by neutralizing the toxic effects of the venom and preventing severe complications such as kidney failure, coagulopathy, or tissue necrosis caused by viper envenomation.
It is administered intravenously, typically in specialized medical facilities, under strict medical supervision. The dosage is determined based on the severity of the bite, the patient's symptoms, and the specific type of viper involved.
Common side effects include allergic reactions such as skin rashes, fever, or itching. In rare cases, severe reactions like anaphylaxis may occur. Additionally, serum sickness, a delayed immune response characterized by fever, joint pain, and skin rashes, can develop days or weeks after treatment.
Anti-viper venom immunoglobulin is a life-saving treatment for severe viper envenomation, but its use requires careful monitoring to manage potential adverse effects. Patients should seek immediate medical attention after a viper bite to ensure timely and effective treatment.
Substance: anti-viperin immunoglobulin
Date of last drug list: 01-07-2015
Commercial code: W61100002
Pharmaceutical form: injectible solution
Quantity: 10
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).